ANALYST RECOMMENDATIONS : Biogen, BAT, Hubbell, Liberty Global, Pentair...

Every day, find a selection of analysts' recommendations covering North AMerica and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.

 

Biogen: Stifel adjusts Price Target on Biogen to $331 from $299, maintains Buy rating.

British American Tobacco: JP Morgan maintains its Buy rating on the stock. Previously set at GBp 4500, the target price is lowered to GBp 4000.

Consolidated Edison: BofA upgrades to Neutral from Underperform, raises PT to $95 from $78.

Expeditors: Exane BNP Paribas initiated coverage with a recommendation of neutral. PT set to $107.

Hubbell: Wolfe Research downgrades to underperform from peerperform. PT down 7.5% to $235.

Liberty Global: J.P. Morgan downgrades to neutral from overweight. PT up 15% to $23.

Pentair: Barclays upgrades to overweight from equal-weight. PT up 20% to $55.

Primary Health: Barclays downgrades to underweight from overweight. PT down 5.7% to 105 pence.

Zebra Tech: Wolfe Research downgrades to underperform from peerperform. PT down 1.6% to $266.